Ugur Sahin; Chief Executive Officer, Member of the Management Board; Biontech SE Oezlem Tuereci; Chief Medical Office, Member of the Management Board; Biontech SE Welcome to BioNTech's first-quarter ...

Q1 2025 Earnings Call Transcript May 5, 2025 Operator: Welcome to BioNTech’s First Quarter 2025 Earnings Call. I would like ...

BioNTech invites investors and the general public to join a conference call and webcast with investment analysts today, May 5, 2025, at 8:00 a.m. EDT (2:00 p.m. CEST) to report its financial results ...

BioNTech reported a net loss of €415.8 million for the quarter, wider than the €315.1 million loss in the same period last year. The increased loss was attributed to higher research and development ...

Continued oncology pipeline advancement with a strategic focus on two priority pan-tumor programs: next-generation immunomodulator BNT327, a bispecific antibody targeting PD-L1 and VEGF-A1, and mRNA c ...

CEO and co-founder of BioNTech, Professor Ugur Sahin, MD, said: “By combining both indications in one vaccine approach, we aim to provide individuals with an efficient way to receive ...

“We see a significant opportunity at the intersection of AI and immunology by computational design of new precision immunotherapies,” said BioNTech chief executive Ugur Sahin. “This ...

Bojan Pancevski is The Wall Street Journal’s chief European political correspondent, covering European and global affairs. He ...

EU residents will have access to Omicron-adapted vaccines before the start of the winter season," said Prof Ugur Sahin, BioNTech's chief executive. The companies said they are also planning to ...

"Adults aged 50 years and older as well as vulnerable populations like cancer patients are at an increased risk of shingles," said BioNTech's chief executive Ugur Sahin, who was raised and ...

as we all experience that drug development can be accelerated without cutting corners if everyone works seamlessly together towards the same goal,” stated Ugur Sahin, CEO of BioNTech ...

BioNTech chief executive Ugur Sahin said that while vaccines continue to offer protection against severe disease caused by Omicron, "emerging data indicate vaccine-induced protection against ...